NCT02153528View on ClinicalTrials.gov

Optimization of the TB Treatment Regimen Cascade

PHASE3CompletedINTERVENTIONAL
Enrollment

701

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 1, 2017

Study Completion Date

August 1, 2017

Conditions
Tuberculosis, Pulmonary
Interventions
DRUG

double rimfampicin

Compared to standard regimen dosing of rifampicin is doubled, while standard dose isoniazid, pyrazinamide and ethambutol are maintained

DRUG

Standard TB treatment

Standard regimen for TB treatment according to guidelines of the International Union against Tuberculosis and Lung Disease

Trial Locations (1)

Unknown

Damien Foundation Bangladesh TB project in Greater Mymensingh district (8 selected clinics), Dhaka

All Listed Sponsors
collaborator

National TB control Programme Bangladesh

OTHER

collaborator

Institute of Tropical Medicine, Belgium

OTHER

lead

Damien Foundation

OTHER

NCT02153528 - Optimization of the TB Treatment Regimen Cascade | Biotech Hunter | Biotech Hunter